We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smartphone-Based Technique Helps Doctors Assess Hematological Disorders

By LabMedica International staff writers
Posted on 01 Jun 2020
As one of the most common clinical laboratory tests, blood hemoglobin tests are routinely ordered as an initial screening of reduced red blood cell production to examine the general health status before other specific examinations.

Blood hemoglobin tests are extensively performed for a variety of patient care needs, such as anemia detection as a cause of other underlying diseases, assessment of hematologic disorders, transfusion initiation, hemorrhage detection after traumatic injury, and acute kidney injury.

Biomedical Engineers at Purdue University (West Lafayette, IN, USA) and their colleagues have developed a way to use smartphone images of a person's eyelids to assess blood hemoglobin levels. More...
The ability to perform one of the most common clinical laboratory tests without a blood draw could help reduce the need for in-person clinic visits, make it easier to monitor patients who are in critical condition, and improve care in low- and middle-income countries where access to testing laboratories is limited.

The scientists tested the new technique, called mHematology, with 153 volunteers who were referred for conventional blood tests at the Moi University Teaching and Referral Hospital (Eldoret, Kenya). They used data from a randomly selected group of 138 patients to train the algorithm, and then tested the mobile health app with the remaining 15 volunteers. The results showed that the mobile health test could provide measurements comparable to traditional blood tests over a wide range of blood hemoglobin values.

The team created a mobile health version of the analysis by using an approach known as spectral super-resolution spectroscopy. This technique uses software to virtually convert photos acquired with low-resolution systems such as a smartphone camera into high-resolution digital spectral signals. They selected the inner eyelid as a sensing site because microvasculature is easily visible there; it is easy to access and has relatively uniform redness. The inner eyelid is also not affected by skin color, which eliminates the need for any personal calibrations. The prediction errors for the smartphone technique were within 5% to 10% of those measured with clinical laboratory blood.

Young L. Kim, PhD, MSCI, an associate professor and senior author of the study said, “Our new mobile health approach paves the way for bedside or remote testing of blood hemoglobin levels for detecting anemia, acute kidney injury and hemorrhages, or for assessing blood disorders such as sickle cell anemia.” The study was published on May 21, 2020 issue of the journal Optica.

Related Links:
Purdue University
Moi University Teaching and Referral Hospital



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Portable Electronic Pipette
Mini 96
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The genomic test measures eight gene activities in a melanoma tumor and combines this data with patient factors like age and tumor thickness (Photo courtesy of 123RF)

Genomic Test Could Reduce Lymph Node Biopsy Surgery in Melanoma Patients

Accurately determining whether melanoma has spread to the lymph nodes is crucial for guiding treatment decisions, yet the standard procedure—sentinel lymph node biopsy—remains invasive, costly, and unnecessary... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.